Compound class:
Synthetic organic
Comment: SC83288 is an amicarbalide derivative and the clinical development candidate for this novel antimalarial chemotype [2].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
Guide to Malaria Pharmacology Comments |
SC83288 has a different mechanism of action and no cross resistance to the artemisinin class of antimalarial compounds [1], supporting the clinical development of SC83288 as alternative treatment for severe malaria in areas affected by artemisinin-resistance. Potential Target/Mechanism Of Action: As the precise mechanism of action of SC83288 is not yet known, we do not have a molecular target for this compound. |